{"version":"1.0","provider_name":"Dorantes Advisors","provider_url":"https:\/\/dorantesadvisors.com\/en","author_name":"Dorantes Advisors","author_url":"https:\/\/dorantesadvisors.com\/en\/author\/admin\/","title":"Abre TPP 'ventana' a gen\u00e9ricos - Dorantes Advisors","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"dpkVOCLFwi\"><a href=\"https:\/\/dorantesadvisors.com\/en\/case\/abre-tpp-ventana-a-genericos\/\">Abre TPP &#8216;ventana&#8217; a gen\u00e9ricos<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/dorantesadvisors.com\/en\/case\/abre-tpp-ventana-a-genericos\/embed\/#?secret=dpkVOCLFwi\" width=\"600\" height=\"338\" title=\"&#8220;Abre TPP &#8216;ventana&#8217; a gen\u00e9ricos&#8221; &#8212; Dorantes Advisors\" data-secret=\"dpkVOCLFwi\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/dorantesadvisors.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","thumbnail_url":"https:\/\/dorantesadvisors.com\/wp-content\/uploads\/2020\/03\/2517753.jpg","thumbnail_width":420,"thumbnail_height":280,"description":"Norma Z\u00fa\u00f1iga Cd. de M\u00e9xico (09 noviembre 2015).- En el Acuerdo de Asociaci\u00f3n Transpac\u00edfica (TPP, por sus siglas en ingl\u00e9s) hay una ventana de acceso para los medicamentos gen\u00e9ricos. Juan Antonio Dorantes S\u00e1nchez, director general de reglas de comercio internacional de la Secretar\u00eda de Econom\u00eda, se\u00f1al\u00f3 que M\u00e9xico tendr\u00e1 la opci\u00f3n de quitar el derecho"}